Vasa Denticity (DENTALKART)
TurnaroundFairStock Score: 15/100 — RISKY
Score breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹563.1 |
| Market Cap | ₹901.87 Cr |
| P/E Ratio | 56.7 |
| ROCE | 22.42% |
| ROE | —% |
| Dividend Yield | 0% |
| Profit Growth | -60.9% |
| Debt/Equity | — |
| Sales Growth | 13.75% |
| Promoter Holding | 60.19% |
| 52-Week Range | ₹322.5 — ₹635.6 |
| Sector | Healthcare Equipment & Supplies |
Strengths
- ROCE of 22.42% suggests decent capital efficiency
- Sales growth of 13.75% and latest quarter revenue of ₹71 Cr show demand traction
- Promoter holding of 60.19% aligns management interests with shareholders
- Listed in the medical equipment and supplies space, which offers recurring demand potential
Concerns
- Profit growth of -60.90% with latest quarter net profit of only ₹2 Cr on ₹71 Cr sales indicates severely compressed margins
- P/E of 56.70 and PEG of 4.12 are expensive given the sharp earnings decline
- Piotroski F-Score of 4/9 and FairStock Score of 11/100 suggest weak financial health and high risk
- No dividend and unavailable book value/debt data limit any margin-of-safety assessment
AI Analysis
When I look at Vasa Denticity, I first ask whether the business earns a good return on capital. ROCE at 22.42% is respectable, but a P/E of 56.70 with profit growth of -60.90% makes little sense unless the earnings recovery is swift and powerful. The latest quarter shows sales of ₹71 Cr but net profit of only ₹2 Cr; that is a paper-thin margin. Sales growth of 13.75% is decent, but profitable growth is what matters. A PEG of 4.12 tells me I am paying a heavy price for moderate growth. Graham would insist on a margin of safety. Here the stock is down from its 52-week high of ₹679.95, but a falling price is not the same as an undervalued price. The Piotroski F-Score of 4/9 points to weak financial health, and a dividend yield of 0.00% means I cannot get paid while waiting. Promoter holding at 60.19% is a positive, and the 22.42% ROCE suggests some capital efficiency. But I do not invest on hope; I need evidence of stable earnings. With profit down 60.90% and only ₹2 Cr net profit in the latest quarter, this business is not earning its valuation today. The FairStock Score of 11/100 is a warning flag, not a buy signal. Graham would say this is a speculation dressed in numbers. I would wait on the sidelines until margins recover, sales momentum continues, and the price offers a real margin of safety.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer